Perfromance Wealth Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.48M Sell
5,820
-230
-4% -$53.6K 0.04% 79
2026
Q1
$1.48M Buy
+6,050
New +$1.41M 0.04% 71
2023
Q4
Sell
-53,086
Closed -$8.27M 173
2023
Q3
$8.27M Buy
53,086
+660
+1% +$109K 0.4% 23
2023
Q2
$8.54M Sell
52,426
-1,965
-4% -$317K 0.39% 22
2023
Q1
$8.43M Buy
54,391
+117
+0.2% +$18.9K 0.43% 24
2022
Q4
$9.59M Sell
54,274
-1,174
-2% -$203K 0.58% 17
2022
Q3
$9.06M Buy
55,448
+2,731
+5% +$462K 0.52% 21
2022
Q2
$9.36M Buy
52,717
+18,512
+54% +$3.3M 0.53% 23
2022
Q1
$6.06M Buy
34,205
+21,869
+177% +$3.72M 0.26% 33
2021
Q4
$2.11M Buy
+12,336
New +$2.02M 0.09% 58

Other funds holding JNJ

Perfromance Wealth Partners's JNJ Position: Q2 2026 in Review

Perfromance Wealth Partners reduced its Johnson & Johnson (JNJ) stake by 3.8% in Q2 2026, selling an estimated $53.6K and leaving 5,820 shares worth $1.48M. The position accounts for 0.04% of the portfolio, ranked #79.

Perfromance Wealth Partners first reported a position in JNJ in Q4 2021 and has held it in 10 quarters since. The position peaked at $9.59M in Q4 2022. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Perfromance Wealth Partners held 5,820 shares of Johnson & Johnson worth $1.48M as of Q2 2026.
  • Perfromance Wealth Partners sold 230 Johnson & Johnson shares in Q2 2026, an estimated $53.6K.
  • Johnson & Johnson made up 0.04% of Perfromance Wealth Partners's portfolio in Q2 2026, its #79 holding.
  • Perfromance Wealth Partners first reported a position in Johnson & Johnson in Q4 2021 and has held it in 10 quarters since.
  • Perfromance Wealth Partners's Johnson & Johnson position peaked at $9.59M in Q4 2022.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Perfromance Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.